Literature DB >> 30468645

Loss of balance in normal GPCR-mediated cell trafficking.

Otavio Cabral-Marques1, Alexandre Henrique Carvalho-Marques1, Lena F Schimke1, Harald Heidecke2, Gabriela Riemekasten3.   

Abstract

G protein-coupled receptors (GPCRs) form a most diverse family of integral membrane proteins that mediate homeostatic and pathological processes, most notably by orchestrating cell distribution throughout the body, their infiltration, and time of presence in inflamed tissues. Here we discuss loss-of-orientation-effects in GPCR-mediated cell trafficking and migration and their impact on the phenotype of autoimmune diseases. In this context, we provide a systemic and integrative view of the contribution of abnormal GPCR expression as well as the levels of natural ligands and functional autoantibodies to the phenotype of autoimmune diseases. Currently, several studies propose that functional autoantibodies (including those targeting GPCRs) constitute an exclusively pathogenic or pathognomonic phenomenon. Here we reinforce the need of revising this point of view, and suggest that functional autoantibodies primary play a role in normal human physiology, while dysregulation of their functions causes autoimmune disease. Because patients with autoimmune diseases still suffer from severe morbidity and mortality rates, we consider expanding our knowledge on (patho)physiological roles of GPCR as a prerequisite for the development of novel specific therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30468645     DOI: 10.2741/4707

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  4 in total

Review 1.  Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation.

Authors:  Otavio Cabral-Marques; Lena F Schimke; Edgar Borges de Oliveira; Nadia El Khawanky; Rodrigo Nalio Ramos; Basel K Al-Ramadi; Gesmar Rodrigues Silva Segundo; Hans D Ochs; Antonio Condino-Neto
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

2.  Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis.

Authors:  Lucy Kappes; Ruba L Amer; Sabine Sommerlatte; Ghada Bashir; Corinna Plattfaut; Frank Gieseler; Timo Gemoll; Hauke Busch; Abeer Altahrawi; Ashraf Al-Sbiei; Shoja M Haneefa; Kholoud Arafat; Lena F Schimke; Nadia El Khawanky; Kai Schulze-Forster; Harald Heidecke; Anja Kerstein-Staehle; Gabriele Marschner; Silke Pitann; Hans D Ochs; Antje Mueller; Samir Attoub; Maria J Fernandez-Cabezudo; Gabriela Riemekasten; Basel K Al-Ramadi; Otavio Cabral-Marques
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

3.  Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.

Authors:  Lukas Bankamp; Beate Preuß; Ann-Christin Pecher; Nicola Beucke; Jörg Henes; Reinhild Klein
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

Review 4.  Vaccines against components of the renin-angiotensin system.

Authors:  Noé Francisco Garay-Gutiérrez; Carolina Paz Hernandez-Fuentes; Gerardo García-Rivas; Sergio Lavandero; Carlos Enrique Guerrero-Beltrán
Journal:  Heart Fail Rev       Date:  2020-09-29       Impact factor: 4.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.